We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
+$276M
Cap. Flow
+$178M
Cap. Flow %
10.22%
Top 10 Hldgs %
26.57%
Holding
376
New
39
Increased
143
Reduced
134
Closed
9

Top Buys

Rank Stock Value
1
DFUS
Dimensional US Equity ETF
DFUS
+$53.3M
2
DFAT icon
Dimensional US Targeted Value ETF
DFAT
+$48.6M
3
DFAC icon
Dimensional US Core Equity 2 ETF
DFAC
+$28.7M
4
DFAS icon
Dimensional US Small Cap ETF
DFAS
+$28.3M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$5.26M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$1.93M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$1.82M
3
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M
4
MZTI
The Marzetti Company
MZTI
+$1.18M
5
IWC icon
iShares Micro-Cap ETF
IWC
+$1.17M

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.47%
2 Technology 15.8%
3 Financials 10.71%
4 Healthcare 10.19%
5 Consumer Staples 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWTR
351
DELISTED
Twitter, Inc.
TWTR
$210K 0.01%
+3,055
New +$187K
IUSG icon
352
iShares Core S&P US Growth ETF
IUSG
$33.5B
$209K 0.01%
2,073
-890
-30% -$85.8K
ARCC icon
353
Ares Capital
ARCC
$14.3B
$208K 0.01%
10,620
– –
SCHP icon
354
Schwab US TIPS ETF
SCHP
$16.5B
$204K 0.01%
+6,512
New +$202K
WOR icon
355
Worthington Enterprises
WOR
$2.8B
$204K 0.01%
5,421
– –
ALL icon
356
Allstate
ALL
$65.9B
$202K 0.01%
+1,548
New +$200K
CTAS icon
357
Cintas
CTAS
$81.7B
$202K 0.01%
2,120
-352
-14% -$31.2K
GOF icon
358
Guggenheim Strategic Opportunities Fund
GOF
$2.15B
$201K 0.01%
+9,267
New +$195K
IYF icon
359
iShares US Financials ETF
IYF
$4.31B
$200K 0.01%
+2,470
New +$199K
GPX
360
DELISTED
GP Strategies Corp.
GPX
$194K 0.01%
12,326
+641
+5% +$10.4K
GRFS
361
Grifois
GRFS
$5.23B
$190K 0.01%
10,969
+14
+0.1% +$251
IEZ icon
362
iShares US Oil Equipment & Services ETF
IEZ
$386M
$153K 0.01%
10,000
– –
SRTA
363
Strata Critical Medical Inc
SRTA
$528M
$105K 0.01%
+10,000
New +$98.7K
ADMS
364
DELISTED
Adamas Pharmaceuticals
ADMS
$84K ﹤0.01%
16,000
+3,000
+23% +$15.5K
FBIO icon
365
Fortress Biotech
FBIO
$92.4M
$71K ﹤0.01%
1,333
– –
GERN icon
366
Geron
GERN
$970M
$55K ﹤0.01%
39,047
– –
RGLS
367
DELISTED
Regulus Therapeutics
RGLS
$10K ﹤0.01%
1,200
– –
BABA icon
368
Alibaba
BABA
$296B
– –
-1,390
Closed -$315K
BCRX icon
369
BioCryst Pharmaceuticals
BCRX
$2.51B
– –
-11,000
Closed -$112K
CRWD icon
370
CrowdStrike
CRWD
$224B
– –
-7,028
Closed -$321K
CTVA icon
371
Corteva
CTVA
$56B
– –
-4,300
Closed -$200K
KYNB
372
Kyntra Bio
KYNB
$32.5M
– –
-258
Closed -$224K
NMFC icon
373
New Mountain Finance
NMFC
$712M
– –
-34,325
Closed -$426K
TSLX icon
374
Sixth Street Specialty
TSLX
$1.79B
– –
-19,374
Closed -$407K
TSM icon
375
TSMC
TSM
$2.17T
– –
-2,112
Closed -$250K
12 13 14
15
16

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q2 2021 Portfolio in Review

As of Q2 2021, Dowling & Yahnke held 376 positions worth $1.74B, up 19% from $1.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Dowling & Yahnke deployed $178M of net new capital in Q2 2021, opening 39 new positions and adding to 143 existing holdings. Its largest new stake was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 31% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bank of America, an estimated $1.93M trimmed.

  • Dowling & Yahnke's largest Q2 2021 buy was Dimensional US Equity ETF: 1,143,816 shares worth $53.9M.
  • Dowling & Yahnke added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $5.26M increase.
  • Dowling & Yahnke's biggest Q2 2021 reduction was Bank of America, cutting an estimated $1.93M.
  • Dowling & Yahnke fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $1.82M.
  • Dowling & Yahnke's ten largest holdings make up 27% of its $1.74B portfolio in Q2 2021.
  • Dowling & Yahnke opened 39 new positions and closed 9 in Q2 2021.
  • Dowling & Yahnke's portfolio value rose 19% quarter-over-quarter to $1.74B.

Based on Dowling & Yahnke's 13F filing for Q2 2021, filed 21 Jul 2021.